Anvajo
A Dresden-based technology company that develops, manufactures and sells innovative solutions for the analysis of liquids.
| EUR | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 113 % | (8 %) | 23 % | 16 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (208 %) | (209 %) | (272 %) | (298 %) | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Dealroom estimates
Related Content
Anvajo is a pioneering developer and manufacturer of point of care solutions for laboratory diagnostic testing of liquids. The company's flagship product, the fluidlab, is a compact, handheld device that combines microscopy and spectrometry to provide rapid, accurate, and quantitative analysis of various fluids, including blood, urine, sperm, and water. This innovative platform is designed to be easy to use, portable, and cost-effective, making it ideal for field usage in structurally underdeveloped regions. Anvajo primarily serves healthcare providers, laboratories, and research institutions, offering them a reliable and efficient tool for fluid diagnostics. The company's business model revolves around the sale of the fluidlab devices and associated consumables, generating revenue through direct sales and partnerships. By addressing the need for accessible and precise diagnostic tools, Anvajo is positioned in the growing market of point of care testing technologies.
Keywords: point of care, fluid diagnostics, microscopy, spectrometry, handheld device, healthcare, laboratory testing, portable, quantitative analysis, innovative platform.